Delivery Order SPE2DB22D1002-SPE2DB25FLBW5
Award Date
5/7/25
Potential Completion Date
5/8/25
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,722.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with an ultimate completion date of April 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides...
The federal contract award, identified as SPE2DB22D1103|SPE2DB25FTJM4, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,080.54, is for the delivery of the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. This is a firm-fixed-price delivery order contract with an ultimate completion date of April 3, 2025. The contract is not designated with a set-aside requirement,...
This federal contract award, valued at $4,822.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication WEGOVY 0.5 MG/0.5 ML PEN 0.5ML, with a performance period ending on May 6, 2025. This contract is not set-aside and was awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,276.00, is for the delivery of the drug WEGOVY 0.5 MG/0.5 ML PEN 0.5ML. It is a firm fixed-price delivery order contract with a completion date of January 16, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,917.70, is a delivery order for the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. It is a firm fixed-price contract with an ultimate completion date of April 22, 2025. This contract is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,936.13, is for the delivery of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,686.16, is for the delivery of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This is a firm fixed-price delivery order contract with a completion date of February 10, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,410.50 and a period of performance through March 17, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, with ID SPE2DB25D3007|SPE2DB25FWRHN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a ceiling value of $1,924.96 and a period of performance through April 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, identified as SPE2DB20D1004|SPE2DB25FNGJH, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,772.68 firm fixed-price delivery order is for the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, with a performance period through April 16, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...